New center to fund ‘most exciting’ biomedical discoveries
On Jan. 30, 2020, the University of Washington (UW) announced that a new center was being created with…
23andMe signed a strategic agreement with Almirall
On Jan. 29, 2020, 23andMe announced an agreement with Almirall to in-license 23andMe’s bispecific monoclonal antibody designed to…
Sorrento and Celularity to initiate emergency allogeneic natural killer cell therapy development for Coronavirus infection
On Jan. 29, 2020, Sorrento announced it had produced a preclinical batch of the STI-4398 (COVIDTRAP) protein to…
WHO, China leaders discuss next steps in battle against coronavirus outbreak
On Jan. 28, 2020, the Director-General of the World Health Organization (WHO), Dr. Tedros Adhanom Ghebreyesus, met President…
AbCellera mobilized response to the novel coronavirus outbreak as part of its DARPA P3 program
On Jan. 28, 2020, AbCellera confirmed that it had mobilized its pandemic response platform against the ongoing outbreak…
Alexion completed acquisition of Achillion for $930 million
On Jan. 28, 2020, Alexion Pharma announced it had completed its acquisition of Achillion Pharmaceuticals for $930 million….
Artificial Intelligence | Biotechnology | Diagnostics | Life Science News | Medical Device | Non-Profit Research | Therapeutics
Northeastern partners with entrepreneur David Roux to launch the Roux Institute at Northeastern University
On Jan. 27, 2020, the Jackson Laboratory announced it was one of the founding partners of the Roux…
The Cancer Prevention and Research Institute of Texas announced it had recruited its 200th CPRIT scholar
On Jan. 27, 2020, the Cancer Prevention and Research Institute of Texas (CPRIT) announced it had recruited its…
Bill & Melinda Gates Foundation donated $10 million to global response to 2019-nCOV
On Jan. 26, 2020, the Bill & Melinda Gates Foundation announced that it had immediately committed $10 million…
World’s first meningitis B national infant vaccination programme showed 75% drop in cases over three years
On Jan. 23, 2020, two independent meningitis B studies were published in the New England Journal of Medicine…
Vanderbilt University Medical Center researchers announced new insight on diabetic retinopathy
On Jan. 23, 2020, Vanderbilt University Medical Center researchers Megan Capozzi, PhD, John Penn, PhD, and colleagues showed…
Vir Biotec applying multiple platforms to address public health risk from coronavirus
On Jan. 22, 2020, Vir Biotech announced it was working to rapidly determine whether its previously identified anti-coronavirus…
Lack of new antibiotics threatens global efforts to contain drug-resistant infections
On Jan. 17, 2020, the World Health Organization (WHO) reported that declining private investment and lack of innovation…
Karmanos Cancer Institute was awarded the President’s Trophy for second year in a row by McLaren Health Care
On Jan. 16, 2020, the Barbara Ann Karmanos Cancer Institute received the President’s Trophy for the second year…
US DoD exercised option for IXIARO vaccine for Japanese encephalitis with Valneva
On Jan. 14, 2020, Valneva announced that the U.S. Department of Defense (DoD) had exercised an option to…
Just – Evotec Biologics initiated construction of first JPOD Facility in North America
On Jan. 14, 2020, Evotec announced that the wholly-owned Seattle based company Just – Evotec Biologics had initiated…
Secretary Azar declared Public Health Emergency for the U.S. for 2019 Novel Coronavirus
On Jan 31, 2020, Health and Human Services Secretary Alex M. Azar II declared a public health emergency…
Cleveland Clinic study identified genetic anomaly associated with poor response to common asthma treatment
On Jan. 13, 2020, a new Cleveland Clinic study uncovered a genetic anomaly associated with poor response to…
Biotechnology | Diagnostics | Life Science History | Life Science News | Non-Profit Research | Therapeutics
Vanderbilt researchers discovered a new genetic disease
On Jan. 13, 2020, Vanderbilt University Medical Center researcher Ela Knapik, MD and her colleagues announced they had…
Biotechnology | Diagnostics | Life Science History | Life Science News | Neurology | Non-Profit Research | Therapeutics
Mayo Clinic research discovered a molecular switch for repairing central nervous system disorders
On Jan. 10, 2020, Mayo Clinic researchers reported that they had discovered a molecular switch for repairing central…
Mayo Clinic sequenced 100K participants to build genomic database for improved care and research in collaboration with Helix
On Jan. 9, 2020, Mayo Clinic announced it was creating a library of genomic sequencing data on 100,000…
Penn Medicine birth marked a milestone in uterus transplant clinical trial
On Jan. 9, 2020, Penn Medicine announced the birth of Benjamin Thomas Gobrecht: his mother, 33-year-old Jennifer Gobrecht,…
O’Neal Cancer Center welcomed Sleckman as new director
On Jan. 8, 2020, the University of Alabama at Birmingham Comprehensive Cancer Center (UAB) announced that world-renowned researcher…
Xencor and Gilead entered license agreement for use of XmAb antibody technologies in investigational agents for HIV
On Jan. 8, 2020, Xencor announced a technology license agreement in which Gilead Sciences will access Xencor’s Xtend…
FDA approved 3D-printed airway stents developed by Cleveland Clinic doctor
On Jan. 8, 2020, the U.S. Food and Drug Administration (FDA) approved patient-specific airway stents developed by Cleveland…
Thomas J Lynch Jr became the sixth president of the Fred Hutchinson Cancer Research Center
On Jan. 7, 2020, the Fred Hutchinson Cancer Research Center announced Dr. Thomas J. Lynch Jr. as the…
Karmanos Cancer Institute received the 2020 Women’s Choice Award
On Dec. 23, 2019, the Barbara Ann Karmanos Cancer Institute received the 2020 Women’s Choice Award as one…
The FDA approved new treatment option for patients with HER2-positive breast cancer
On Dec. 20, 2019, the U.S. Food and Drug Administration (FDA) granted accelerated approval to Daiichi Sankyo’s Enhertu…
The Jackson Laboratory received $2.5 million from The Mark Foundation for breakthrough cancer immunotherapy project
On Dec. 18, 2019, the Jackson Laboratory received $2.5 million from The Mark Foundation for breakthrough cancer immunotherapy…
FDA granted accelerated approval to Astellas and Seagen PADCEV for people with locally advanced or metastatic urothelial cancer
On Dec. 18, 2019, Seagen and Astellas Pharma announced the U.S. Food and Drug Administration (FDA) had granted…